Genetic Factors in Congenital Diaphragmatic Hernia

Slides:



Advertisements
Similar presentations
Retinoic Acid Receptor-α (RARα) & its role in Acute Promyelocytic Leukemia (APL) Danielle Matsushima.
Advertisements

Control of Th2-Mediated Inflammation by Regulatory T Cells
Control of Gene Expression
Ligand- and signal-activated transcription factors (represented by the round and the rectangular symbols, respectively) can bind to the promoter regions.
Christine L.H. Snozek, Dennis J. O'Kane, Alicia Algeciras-Schimnich 
Hormones and the Endocrine System
Elisabeth H. Villavicencio, David O. Walterhouse, Philip M. Iannaccone 
p53 and Apoptosis: It's Not Just in the Nucleus Anymore
Notch: Filling a Hole in T Helper 2 Cell Differentiation
Hadas Ben-Sasson, M. Sc. , Assaf Ben-Meir, M. D. , Asher Shushan, M. D
Figure 2 Oestrogen receptor signalling pathways
Abiotic Stress Signaling and Responses in Plants
The Aldo-Keto Reductase AKR1B10 Is Up-Regulated in Keloid Epidermis, Implicating Retinoic Acid Pathway Dysregulation in the Pathogenesis of Keloid Disease 
Caught in the Akt: Regulation of Wnt Signaling in the Intestine
Kaitlin A. Read, Michael D. Powell, Paul W. McDonald, Kenneth J
Mark S. Nanes, M.D., Ph.D., Caleb B. Kallen, M.D., Ph.D. 
Unit III Information Essential to Life Processes
Immunolocalization of Enzymes, Binding Proteins, and Receptors Sufficient for Retinoic Acid Synthesis and Signaling During the Hair Cycle  Helen B. Everts,
Mean-Independent Noise Control of Cell Fates via Intermediate States
Gene Therapy for β-Hemoglobinopathies
CHAPTER 11 The Control of Gene Expression
Chromatin Proteins Do Double Duty
Volume 91, Issue 1, Pages 2-3 (January 2017)
Ontogeny of the ovary in polycystic ovary syndrome
The Role of Retinoic Acid in Tolerance and Immunity
Take out a sheet of paper for a new page of notes
Tyrosinase: A Central Regulatory Protein for Cutaneous Pigmentation
Enlightening the adrenal gland
Chronic Diarrhea Due to Excessive Bile Acid Synthesis and Not Defective Ileal Transport: A New Syndrome of Defective Fibroblast Growth Factor 19 Release 
Volume 73, Issue 1, Pages 5-7 (January 2008)
Long Noncoding RNA in Hematopoiesis and Immunity
The Bare Lymphocyte Syndrome: Molecular Clues to the Transcriptional Regulation of Major Histocompatibility Complex Class II Genes  Angela DeSandro, Uma.
Christine L.H. Snozek, Dennis J. O'Kane, Alicia Algeciras-Schimnich 
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
CDK Inhibitors: Cell Cycle Regulators and Beyond
Proteins Kinases: Chromatin-Associated Enzymes?
Andrew Johnston  Journal of Investigative Dermatology 
Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis  Kosaku Uyeda,
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
Retinoic Acid Synthesis and Signaling during Early Organogenesis
The Role of Neuronal Complexes in Human X-Linked Brain Diseases
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases  Jennifer W. Leiding, MD, Lisa.
Lan-Hsin Wang, Nicholas E. Baker  Developmental Cell 
Retinoids in nephrology: Promises and pitfalls
Alexander Kiani, Anjana Rao, Jose Aramburu  Immunity 
Metabolic Regulation by p53 Family Members
Slugging It out: Fine Tuning the p53-PUMA Death Connection
The Thyroid and Metabolism: The Action Continues
Keratinocyte-Specific Retinoid Regulation of Human Cellular Retinoic Acid Binding Protein-II (hCRABPII) Gene Promoter Requires an Evolutionarily Conserved.
Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis  Kosaku Uyeda,
Shared Principles in NF-κB Signaling
Molecular origin of the kidney clock
The RAS-MEK-ERK pathway represents a chain of protein signalling pathway that responds to a mitogen binding to a cell surface receptor. The RAS-MEK-ERK.
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
The Stressed CNS: When Glucocorticoids Aggravate Inflammation
Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety  Philippe Bouchard, M.D., Nathalie Chabbert-Buffet,
Volume 119, Issue 4, Pages (October 2000)
Guilty as charged Cancer Cell
Heather M. Young, Lincon A. Stamp  Gastroenterology 
William H. Catherino, M.D., Ph.D., Minnie Malik, Ph.D. 
Regulation of p53 by MDM2. p53 and MDM2 form an autoregulatory feedback loop. p53 stimulates the expression of MDM2; MDM2, in turn, inhibits p53 activity.
Volume 7, Issue 1, Pages 1-11 (July 1997)
Congenital Diaphragmatic Hernia and Chromosome 15q26: Determination of a Candidate Region by Use of Fluorescent In Situ Hybridization and Array-Based.
Hinrich Gronemeyer, Arthur Zelent  Cancer Cell 
How to fix a broken clock
Immunolocalization of Enzymes, Binding Proteins, and Receptors Sufficient for Retinoic Acid Synthesis and Signaling During the Hair Cycle  Helen B. Everts,
Volume 5, Issue 3, Pages (March 2007)
Overview of molecular JAK signaling.
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
Update on glucocorticoid action and resistance
Presentation transcript:

Genetic Factors in Congenital Diaphragmatic Hernia A.M. Holder, M. Klaassens, D. Tibboel, A. de Klein, B. Lee, D.A. Scott  The American Journal of Human Genetics  Volume 80, Issue 5, Pages 825-845 (May 2007) DOI: 10.1086/513442 Copyright © 2007 The American Society of Human Genetics Terms and Conditions

Figure 1 Chromosomal regions and selected candidate genes for CDH. Recurrent chromosomal abnormalities associated with patients with CDH are represented by colored bars. For each region, the number of patients described with that duplication (red bar), deletion (green bar), or translocation/inversion (blue bar) is given. Selected candidate genes and genetic syndromes are included beside their respective regions. PKS = Pallister-Killian syndrome; WHS = Wolf-Hirschorn syndrome. The American Journal of Human Genetics 2007 80, 825-845DOI: (10.1086/513442) Copyright © 2007 The American Society of Human Genetics Terms and Conditions

Figure 2 Retinoic acid (RA) signaling pathway and CDH candidate genes. Retinol travels to target cells via the blood and is taken up by receptors on the cell surface. Once in the cytoplasm, retinol is converted to retinal by retinol dehydrogenases and then to RA by retinal dehydrogenases, of which RALDH2 is the predominant enzyme. The action of RALDH2 can be inhibited by teratogens, such as nitrofen. Several binding proteins are present in the cytoplasm, including retinol-binding proteins 1 and 2 (RBP1 and RBP2), which bind retinol and retinal, and cellular RA-binding proteins 1 and 2 (CRABP1 and CRABP2). When RA enters the nucleus, it mediates its effects by binding to RA receptors (RARs) and retinoid X receptors (RXRs). RARs and RXRs dimerize and regulate gene expression by binding to short DNA sequences—RA-responsive elements (RAREs) and retinoid X–responsive elements (RXREs)—located in the vicinity of target genes. COUP-TFII expression is upregulated by RA. COUP-TFII can act as a repressor of this pathway by directly sequestering RXR, thereby preventing heterodimerization to RAR and inhibiting gene transcription. This process may be a negative feedback system that precisely balances the transcription of certain genes during diaphragm development. COUP-TFII has been shown to interact physically with FOG2, which, in turn, modulates the transcriptional activity of GATA4, GATA5, and GATA6. The American Journal of Human Genetics 2007 80, 825-845DOI: (10.1086/513442) Copyright © 2007 The American Society of Human Genetics Terms and Conditions